Rigel Pharmaceutical Inc. buy Citigroup Inc.
Start price
07.03.24
/
50%
€1.40
Target price
07.03.25
€3.67
Performance (%)
-47.24%
End price
08.03.25
-
Summary
This prediction is currently being closed. Massive losses of -47.24% have been the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has a follow-up prediction for Rigel Pharmaceutical Inc. where he still thinks Rigel Pharmaceutical Inc. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat
In the thread Trading Rigel Pharmaceutical Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.74
06.03.25
06.03.25
€50.83
06.03.26
06.03.26
-
26.06.24
26.06.24
Stopped prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.74
12.11.24
12.11.24
€46.15
12.11.25
12.11.25
-
13.11.25
13.11.25